Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2021-09-14 15:39:00 UTC |
---|
HMDB ID | HMDB0000153 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Estriol |
---|
Description | Estriol is a metabolite of estrone metabolized via 16alpha-hydroxyestrone through the enzyme 16alpha-hydroxysteroid dehydrogenase (EC 1.1.1.147) or to 2- or 4-hydroxyestrone (catechol estrogens) by the action of catecho-O-methyltransferase (EC 2.1.1.6). The latter metabolites can be formed in the brain and may compete with receptors for catecholamines. Metabolites are conjugated with sulfate or glucuronide before excretion by the kidney. During pregnancy, estriol constitutes 60-70% of the total estrogens, increasing to 300-500-fold in relation to non-pregnant women. The late term human fetus produces relatively large amounts of 16 alphahydroxy DHEA, which serves the mother as a precursor of estriol. It has been shown that 90% of the precursors for the formation of estriol are of fetal origin. If abnormal maternal serum screening results, specifically low levels of unconjugated estriol in the second trimester are detected, a diagnosis of Smith-Lemli-Opitz syndrome (SLOS),or RSH is suspected. SLOS is an autosomal recessive disorder caused by mutations of the gene encoding 7-dehydrocholesterol reductase (EC 1.3.1.21, DHCR7). (PMID: 16202579 , 16112271 , 16097001 ). |
---|
Structure | [H][C@@]12C[C@@H](O)[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3 InChI=1S/C18H24O3/c1-18-7-6-13-12-5-3-11(19)8-10(12)2-4-14(13)15(18)9-16(20)17(18)21/h3,5,8,13-17,19-21H,2,4,6-7,9H2,1H3/t13-,14-,15+,16-,17+,18+/m1/s1 |
---|
Synonyms | Value | Source |
---|
(16alpha,17beta)-Estra-1,3,5(10)-triene-3,16,17-triol | ChEBI | 1,3,5(10)-Estratriene-3,16-alpha,17beta-triol | ChEBI | 16alpha,17beta-Estriol | ChEBI | 16alpha-Hydroxyestradiol | ChEBI | 3,16alpha,17beta-Trihydroxy-Delta(1,3,5)-estratriene | ChEBI | Deuslon-a | ChEBI | Estriel | ChEBI | Oestriol | ChEBI | Trihydroxyestrin | ChEBI | (16a,17b)-Estra-1,3,5(10)-triene-3,16,17-triol | Generator | (16Α,17β)-estra-1,3,5(10)-triene-3,16,17-triol | Generator | 1,3,5(10)-Estratriene-3,16-a,17b-triol | Generator | 1,3,5(10)-Estratriene-3,16-α,17β-triol | Generator | 16a,17b-Estriol | Generator | 16Α,17β-estriol | Generator | 16a-Hydroxyestradiol | Generator | 16Α-hydroxyestradiol | Generator | 3,16a,17b-Trihydroxy-delta(1,3,5)-estratriene | Generator | 3,16Α,17β-trihydroxy-δ(1,3,5)-estratriene | Generator | 3,16a,17b-Trihydroxy-δ(1,3,5)-estratriene | HMDB | 13b-Methyl-1,3,5(10)-gonatriene-3,16a,17b-triol | HMDB | 16-alpha,17-beta-Estriol | HMDB | 16-alpha,17-beta-Oestriol | HMDB | 16-alpha-Hydroxyestradiol | HMDB | 16a-Estriol | HMDB | 16alpha,17beta-Oestriol | HMDB | 16alpha-Hydroxy-17beta-estradiol | HMDB | 16alpha-Hydroxyoestradiol | HMDB | 3,16a,17b-Estriol | HMDB | 3,16a,17b-Trihydroxyestra-1,3,5(10)-triene | HMDB | 3,16alpha,17beta-Trihydroxy-1,3,5(10)-estratriene | HMDB | 3,16alpha,17beta-Trihydroxyestra-1,3,5(10)-triene | HMDB | Aacifemine | HMDB | Colpogyn | HMDB | Colpovister | HMDB | Destriol | HMDB | Deuslon a | HMDB | Estra-1,3,5(10)-triene-3,16a,17b-triol | HMDB | Estratriol | HMDB | Follicular hormone hydrate | HMDB | Gynasan | HMDB | Hemostyptanon | HMDB | Holin V | HMDB | Hormomed | HMDB | Incurin | HMDB | Klimax e | HMDB | Klimoral | HMDB | Oekolp | HMDB | Oestratriol | HMDB | Oestriolum | HMDB | Orestin | HMDB | Orgastyptin | HMDB | Ortho-gynest | HMDB | Ovesterin | HMDB | Ovestin | HMDB | Ovestinon | HMDB | Ovestrion | HMDB | Ovo-vinces | HMDB | Theelol | HMDB | Tridestrin | HMDB | Triovex | HMDB | 16-alpha-Hydroxy-estradiol | HMDB | (16beta,17beta)-Estra-1,3,5(10)-triene-3,16,17-triol | HMDB | 16beta Hydroxy estradiol | HMDB | 16beta-Hydroxy-estradiol | HMDB | Epiestriol | HMDB | 16 alpha Hydroxy estradiol | HMDB | 16alpha,17beta Estriol | HMDB | Estra-1,3,5(10)-triene-3,16beta,17beta-triol | HMDB | 13beta-Methyl-1,3,5(10)-gonatriene-3,16alpha,17beta-triol | HMDB | 13β-Methyl-1,3,5(10)-gonatriene-3,16α,17β-triol | HMDB | 16alpha-Estriol | HMDB | 16α-Estriol | HMDB | 3,16alpha,17beta-Estriol | HMDB | 3,16α,17β-Estriol | HMDB | 3,16α,17β-Trihydroxyestra-1,3,5(10)-triene | HMDB | Estriol | HMDB |
|
---|
Chemical Formula | C18H24O3 |
---|
Average Molecular Weight | 288.3814 |
---|
Monoisotopic Molecular Weight | 288.172544634 |
---|
IUPAC Name | (1S,10R,11S,13R,14R,15S)-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-triene-5,13,14-triol |
---|
Traditional Name | (1S,10R,11S,13R,14R,15S)-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-triene-5,13,14-triol |
---|
CAS Registry Number | 50-27-1 |
---|
SMILES | [H][C@@]12C[C@@H](O)[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3 |
---|
InChI Identifier | InChI=1S/C18H24O3/c1-18-7-6-13-12-5-3-11(19)8-10(12)2-4-14(13)15(18)9-16(20)17(18)21/h3,5,8,13-17,19-21H,2,4,6-7,9H2,1H3/t13-,14-,15+,16-,17+,18+/m1/s1 |
---|
InChI Key | PROQIPRRNZUXQM-ZXXIGWHRSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as estrogens and derivatives. These are steroids with a structure containing a 3-hydroxylated estrane. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Estrane steroids |
---|
Direct Parent | Estrogens and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Estrogen-skeleton
- 3-hydroxysteroid
- 17-hydroxysteroid
- 16-hydroxysteroid
- 16-alpha-hydroxysteroid
- Hydroxysteroid
- Phenanthrene
- Tetralin
- 1-hydroxy-2-unsubstituted benzenoid
- Benzenoid
- Cyclic alcohol
- Secondary alcohol
- 1,2-diol
- Polyol
- Organooxygen compound
- Hydrocarbon derivative
- Alcohol
- Organic oxygen compound
- Aromatic homopolycyclic compound
|
---|
Molecular Framework | Aromatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 282 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | 2.45 | HANSCH,C ET AL. (1995) |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times UnderivatizedChromatographic Method | Retention Time | Reference |
---|
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 5.12 minutes | 32390414 | Predicted by Siyang on May 30, 2022 | 11.9922 minutes | 33406817 | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.71 minutes | 32390414 | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2061.1 seconds | 40023050 | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 247.5 seconds | 40023050 | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 168.7 seconds | 40023050 | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 167.8 seconds | 40023050 | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 274.3 seconds | 40023050 | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 547.4 seconds | 40023050 | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 506.5 seconds | 40023050 | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 83.3 seconds | 40023050 | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 928.9 seconds | 40023050 | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 443.0 seconds | 40023050 | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1377.3 seconds | 40023050 | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 316.7 seconds | 40023050 | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 363.6 seconds | 40023050 | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 300.9 seconds | 40023050 | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 156.9 seconds | 40023050 | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 79.0 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Estriol,1TMS,isomer #1 | C[C@]12CC[C@@H]3C4=CC=C(O)C=C4CC[C@H]3[C@@H]1C[C@@H](O[Si](C)(C)C)[C@@H]2O | 2789.2 | Semi standard non polar | 33892256 | Estriol,1TMS,isomer #2 | C[C@]12CC[C@@H]3C4=CC=C(O)C=C4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O[Si](C)(C)C | 2794.1 | Semi standard non polar | 33892256 | Estriol,1TMS,isomer #3 | C[C@]12CC[C@@H]3C4=CC=C(O[Si](C)(C)C)C=C4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O | 2771.9 | Semi standard non polar | 33892256 | Estriol,2TMS,isomer #1 | C[C@]12CC[C@@H]3C4=CC=C(O[Si](C)(C)C)C=C4CC[C@H]3[C@@H]1C[C@@H](O[Si](C)(C)C)[C@@H]2O | 2842.9 | Semi standard non polar | 33892256 | Estriol,2TMS,isomer #2 | C[C@]12CC[C@@H]3C4=CC=C(O)C=C4CC[C@H]3[C@@H]1C[C@@H](O[Si](C)(C)C)[C@@H]2O[Si](C)(C)C | 2782.1 | Semi standard non polar | 33892256 | Estriol,2TMS,isomer #3 | C[C@]12CC[C@@H]3C4=CC=C(O[Si](C)(C)C)C=C4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O[Si](C)(C)C | 2842.9 | Semi standard non polar | 33892256 | Estriol,3TMS,isomer #1 | C[C@]12CC[C@@H]3C4=CC=C(O[Si](C)(C)C)C=C4CC[C@H]3[C@@H]1C[C@@H](O[Si](C)(C)C)[C@@H]2O[Si](C)(C)C | 2907.4 | Semi standard non polar | 33892256 | Estriol,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)O[C@@H]1C[C@H]2[C@@H]3CCC4=CC(O)=CC=C4[C@H]3CC[C@]2(C)[C@H]1O | 3065.1 | Semi standard non polar | 33892256 | Estriol,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)O[C@H]1[C@H](O)C[C@H]2[C@@H]3CCC4=CC(O)=CC=C4[C@H]3CC[C@@]21C | 3081.3 | Semi standard non polar | 33892256 | Estriol,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC1=CC=C2C(=C1)CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1C[C@@H](O)[C@@H]2O | 3084.3 | Semi standard non polar | 33892256 | Estriol,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=C2C(=C1)CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1C[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]2O | 3374.5 | Semi standard non polar | 33892256 | Estriol,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)O[C@@H]1C[C@H]2[C@@H]3CCC4=CC(O)=CC=C4[C@H]3CC[C@]2(C)[C@H]1O[Si](C)(C)C(C)(C)C | 3303.1 | Semi standard non polar | 33892256 | Estriol,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC1=CC=C2C(=C1)CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1C[C@@H](O)[C@@H]2O[Si](C)(C)C(C)(C)C | 3391.4 | Semi standard non polar | 33892256 | Estriol,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=C2C(=C1)CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1C[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]2O[Si](C)(C)C(C)(C)C | 3664.8 | Semi standard non polar | 33892256 |
|
---|
General References | - Diczfalusy E: The early history of estriol. J Steroid Biochem. 1984 Apr;20(4B):945-53. [PubMed:6374294 ]
- Kashork CD, Sutton VR, Fonda Allen JS, Schmidt DE, Likhite ML, Potocki L, O'Brien WE, Shaffer LG: Low or absent unconjugated estriol in pregnancy: an indicator for steroid sulfatase deficiency detectable by fluorescence in situ hybridization and biochemical analysis. Prenat Diagn. 2002 Nov;22(11):1028-32. [PubMed:12424769 ]
- Furuhashi N, Tsujiei M: [Clinical significance of serum and urinary estriol analysis in endocrine tests of the gonadal and placental system]. Nihon Rinsho. 1989 Dec;48 Suppl:1260-2. [PubMed:2621854 ]
- Ronin-Walknowska E, Szczygielski A, Skoczowska M: [Usefulness of determining free estriol, placental lactogen, progesterone, placental alkaline phosphatase, uric acid, hematocrit, hemoglobin and proteins in the blood and estrogen in the urine in the prognosis of the status of newborn infants in EPH gestosis]. Ginekol Pol. 1987 Jan;58(1):21-6. [PubMed:3583036 ]
- Fredricsson B, Carlstrom K, Eneroth P: Short-term variations in urinary estriol and renal function. Possible effects of extraneous conditions. Gynecol Obstet Invest. 1978;9(5):268-76. [PubMed:752645 ]
- Andreolini F, Borra C, Caccamo F, Di Corcia A, Nicoletti I, Samperi R, Improta F: Estriol and its conjugates in late pregnancy determined by extraction with Carbopack B and liquid chromatography with fluorometric detection. Clin Chem. 1985 Oct;31(10):1698-702. [PubMed:2994907 ]
- Truran PL, Read GF, Walker S: Radioimmunoassay for salivary estriol, with use of an 125I radioligand and a solid-phase separation technique. Clin Chem. 1982 Dec;28(12):2393-7. [PubMed:7139918 ]
- Izumi H, Saito N, Ichiki S, Makino Y, Yukitake K, Kaneoka T: Prenatal diagnosis of congenital lipoid adrenal hyperplasia. Obstet Gynecol. 1993 May;81(5 ( Pt 2)):839-41. [PubMed:8469492 ]
- Guedeney X, Chanez C, Grenier A, Scherrmann JM: Temperature-dependent immunoreactive assay to screen for digoxin-like immunoreactive factor(s). Clin Chem. 1991 Nov;37(11):1900-4. [PubMed:1718632 ]
- Andreolini F, Di Corcia A, Lagana A, Samperi R, Raponi G: Preliminary isolation of urinary placental estriol before gas or liquid chromatography. Clin Chem. 1983 Dec;29(12):2076-8. [PubMed:6640903 ]
- Evans JJ, Wilkinson AR, Aickin DR: Salivary estriol concentrations during normal pregnancies, and a comparison with plasma estriol. Clin Chem. 1984 Jan;30(1):120-1. [PubMed:6690116 ]
- Kono H, Furuhashi N, Shinkawa O, Takahashi T, Tsujiei M, Yajima A: The maternal serum cortisol levels after onset of labor. Tohoku J Exp Med. 1987 Jun;152(2):133-7. [PubMed:3629582 ]
- Moore ML: Biochemical markers for preterm labor and birth: what is their role in the care of pregnant women? MCN Am J Matern Child Nurs. 1999 Mar-Apr;24(2):80-6. [PubMed:10083784 ]
- Pentikainen PJ, Pentikainen LA, Azarnoff DL, Dujovne CA: Plasma levels and excretion of estrogens in urine in chronic lever disease. Gastroenterology. 1975 Jul;69(1):20-7. [PubMed:1171044 ]
- Nutman A, Freud E, Itzhaky D, Dolfin T, Tepper R: High maternal estriol level in pregnancy as a predictor of surgical intervention for undescended testis. Fertil Steril. 2005 Jul;84(1):249-52. [PubMed:16009196 ]
- Pasqualini JR: Enzymes involved in the formation and transformation of steroid hormones in the fetal and placental compartments. J Steroid Biochem Mol Biol. 2005 Dec;97(5):401-15. Epub 2005 Oct 3. [PubMed:16202579 ]
- Lardy H, Marwah A, Marwah P: C(19)-5-ene steroids in nature. Vitam Horm. 2005;71:263-99. [PubMed:16112271 ]
- Shinawi M, Szabo S, Popek E, Wassif CA, Porter FD, Potocki L: Recognition of Smith-Lemli-Opitz syndrome (RSH) in the fetus: utility of ultrasonography and biochemical analysis in pregnancies with low maternal serum estriol. Am J Med Genet A. 2005 Sep 15;138(1):56-60. [PubMed:16097001 ]
- Soldan SS, Alvarez Retuerto AI, Sicotte NL, Voskuhl RR: Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J Immunol. 2003 Dec 1;171(11):6267-74. [PubMed:14634144 ]
- Trimesta [Link]
|
---|